{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:38:17Z","timestamp":1785523097996,"version":"3.56.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"DOI":"10.1038\/s41585-026-01174-3","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:14:04Z","timestamp":1785147244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The urinary microbiome, overactive bladder and bladder pain syndrome\/interstitial cystitis \u2014 mechanisms, diagnostics and therapeutic opportunities"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1153-5249","authenticated-orcid":false,"given":"Martina","family":"Spazzapan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0496-4985","authenticated-orcid":false,"given":"Nicholas","family":"Raison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Steves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"1174_CR1","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin, D. E. et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur. Urol. 50, 1306\u20131315 (2006).","journal-title":"Eur. Urol."},{"key":"1174_CR2","doi-asserted-by":"publisher","first-page":"925834","DOI":"10.3389\/fpain.2022.925834","volume":"3","author":"JT Anger","year":"2022","unstructured":"Anger, J. T. et al. National prevalence of IC\/BPS in women and men utilizing Veterans Health Administration data. Front. Pain Res. 3, 925834 (2022).","journal-title":"Front. Pain Res."},{"key":"1174_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","volume":"21","author":"BT Haylen","year":"2010","unstructured":"Haylen, B. T. et al. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int. Urogynecol. J. 21, 5\u201326 (2010).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet, B. et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur. Urol. 75, 988\u20131000 (2019).","journal-title":"Eur. Urol."},{"key":"1174_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41585-025-01044-4","volume":"22","author":"JF Jhang","year":"2025","unstructured":"Jhang, J. F., Yu, W. R., Jiang, Y. H. & Kuo, H. C. Pathophysiology and potential multimodal therapeutic strategies for IC\/BPS. Nat. Rev. Urol. 22, 672\u2013686 (2025).","journal-title":"Nat. Rev. Urol."},{"key":"1174_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41585-025-01078-8","volume":"23","author":"K Xin","year":"2026","unstructured":"Xin, K. et al. Exploring promising biomarkers based on pathogenic mechanisms in interstitial cystitis\/bladder pain syndrome. Nat. Rev. Urol. 23, 217\u2013235 (2026).","journal-title":"Nat. Rev. Urol."},{"key":"1174_CR7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/nau.23072","volume":"36","author":"R Doggweiler","year":"2017","unstructured":"Doggweiler, R. et al. A standard for terminology in chronic pelvic pain syndromes: a report from the chronic pelvic pain working group of the International Continence Society. Neurourol. Urodyn. 36, 984\u20131008 (2017).","journal-title":"Neurourol. Urodyn."},{"key":"1174_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.eururo.2017.01.037","volume":"72","author":"CR Chapple","year":"2017","unstructured":"Chapple, C. R. et al. Persistence and adherence with mirabegron versus antimuscarinic agents in patients with overactive bladder: a retrospective observational study in UK clinical practice. Eur. Urol. 72, 389\u2013399 (2017).","journal-title":"Eur. Urol."},{"key":"1174_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/toxins18040170","volume":"18","author":"F Cruz","year":"2026","unstructured":"Cruz, F., Michel, M. C. & Igawa, Y. Botulinum toxin type A injections in the bladder wall-an effective treatment for urinary incontinence with low long-term adherence. Toxins 18, 170 (2026).","journal-title":"Toxins"},{"key":"1174_CR10","unstructured":"Engerler, D. et al. EAU Guidelines on Chronic Pelvic Pain (EAU, 2026)."},{"key":"1174_CR11","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1128\/JCM.05852-11","volume":"50","author":"AJ Wolfe","year":"2012","unstructured":"Wolfe, A. J. et al. Evidence of uncultivated bacteria in the adult female bladder. J. Clin. Microbiol. 50, 1376\u20131383 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"1174_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/JCM.02876-13","volume":"52","author":"EE Hilt","year":"2014","unstructured":"Hilt, E. E. et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J. Clin. Microbiol. 52, 871\u2013876 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"1174_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.eururo.2015.02.041","volume":"68","author":"AJ Wolfe","year":"2015","unstructured":"Wolfe, A. J. & Brubaker, L. \u2018Sterile urine\u2019 and the presence of bacteria. Eur. Urol. 68, 173 (2015).","journal-title":"Eur. Urol."},{"key":"1174_CR14","doi-asserted-by":"publisher","first-page":"e01371-20","DOI":"10.1128\/msystems.01371-20","volume":"6","author":"L Brubaker","year":"2021","unstructured":"Brubaker, L. et al. Forming consensus to advance urobiome research. mSystems 6, e01371-20 (2021).","journal-title":"mSystems"},{"key":"1174_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41585-018-0104-z","volume":"15","author":"L Karstens","year":"2018","unstructured":"Karstens, L. et al. Community profiling of the urinary microbiota: considerations for low-biomass samples. Nat. Rev. Urol. 15, 735\u2013749 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"1174_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.21037\/atm.2016.11.62","volume":"5","author":"L Brubaker","year":"2017","unstructured":"Brubaker, L. & Wolfe, A. J. The female urinary microbiota, urinary health and common urinary disorders. Ann. Transl. Med. 5, 34 (2017).","journal-title":"Ann. Transl. Med."},{"key":"1174_CR17","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cmi.2022.08.010","volume":"29","author":"RS Roth","year":"2023","unstructured":"Roth, R. S., Liden, M. & Huttner, A. The urobiome in men and women: a clinical review. Clin. Microbiol. Infect. 29, 1242\u20131248 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"1174_CR18","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1128\/JCM.00044-16","volume":"54","author":"TK Price","year":"2016","unstructured":"Price, T. K. et al. The clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms. J. Clin. Microbiol. 54, 1216 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"1174_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00335-021-09862-8","volume":"32","author":"L Brubaker","year":"2021","unstructured":"Brubaker, L., Putonti, C., Dong, Q. & Wolfe, A. J. The human urobiome. Mamm. Genome 32, 232\u2013238 (2021).","journal-title":"Mamm. Genome"},{"key":"1174_CR20","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.csbj.2021.05.001","volume":"19","author":"MS Matchado","year":"2021","unstructured":"Matchado, M. S. et al. Network analysis methods for studying microbial communities: a mini review. Comput. Struct. Biotechnol. J. 19, 2687\u20132698 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"1174_CR21","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.3390\/diagnostics12123119","volume":"12","author":"HJ Yang","year":"2022","unstructured":"Yang, H. J., Kim, D. S., Lee, K. W. & Kim, Y. H. The urinary microbiome; axis crosstalk and short-chain fatty acid. Diagnostics 12, 3119 (2022).","journal-title":"Diagnostics"},{"key":"1174_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/AOG.0000000000001892","volume":"129","author":"MG Abernethy","year":"2017","unstructured":"Abernethy, M. G. et al. Urinary microbiome and cytokine levels in women with interstitial cystitis. Obstet. Gynecol. 129, 500\u2013506 (2017).","journal-title":"Obstet. Gynecol."},{"key":"1174_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/SPV.0000000000000854","volume":"27","author":"KM Jacobs","year":"2021","unstructured":"Jacobs, K. M. et al. Cultivable bacteria in urine of women with interstitial cystitis: (not) what we expected. Female Pelvic Med. Reconstr. Surg. 27, 322\u2013327 (2021).","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"key":"1174_CR24","doi-asserted-by":"publisher","first-page":"21167","DOI":"10.1038\/s41598-020-78398-9","volume":"10","author":"N Ueda","year":"2020","unstructured":"Ueda, N. et al. Bladder urothelium converts bacterial lipopolysaccharide information into neural signaling via an ATP-mediated pathway to enhance the micturition reflex for rapid defense. Sci. Rep. 10, 21167 (2020).","journal-title":"Sci. Rep."},{"key":"1174_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.chom.2020.06.022","volume":"28","author":"AS Adebayo","year":"2020","unstructured":"Adebayo, A. S. et al. The urinary tract microbiome in older women exhibits host genetic and environmental influences. Cell Host Microbe 28, 298\u2013305.e3 (2020).","journal-title":"Cell Host Microbe"},{"key":"1174_CR26","doi-asserted-by":"publisher","first-page":"1396408","DOI":"10.3389\/fped.2024.1396408","volume":"12","author":"LM Jeries","year":"2024","unstructured":"Jeries, L. M., Sysoeva, T. A., Karstens, L. & Kelly, M. S. Synthesis of current pediatric urinary microbiome research. Front. Pediatr. 12, 1396408 (2024).","journal-title":"Front. Pediatr."},{"key":"1174_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.euf.2018.08.001","volume":"6","author":"P Bajic","year":"2020","unstructured":"Bajic, P. et al. Male bladder microbiome relates to lower urinary tract symptoms. Eur. Urol. Focus 6, 376\u2013382 (2020).","journal-title":"Eur. Urol. Focus"},{"key":"1174_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jpurol.2022.02.025","volume":"18","author":"DW Storm","year":"2022","unstructured":"Storm, D. W. et al. A child\u2019s urine is not sterile: a pilot study evaluating the pediatric urinary microbiome. J. Pediatr. Urol. 18, 383\u2013392 (2022).","journal-title":"J. Pediatr. Urol."},{"key":"1174_CR29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00192-013-2325-2","volume":"25","author":"L Brubaker","year":"2014","unstructured":"Brubaker, L. et al. Urinary bacteria in adult women with urgency urinary incontinence. Int. Urogynecol. J. 25, 1179\u20131184 (2014).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR30","doi-asserted-by":"publisher","first-page":"e01283-14","DOI":"10.1128\/mBio.01283-14","volume":"5","author":"MM Pearce","year":"2014","unstructured":"Pearce, M. M. et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 5, e01283-14 (2014).","journal-title":"mBio"},{"key":"1174_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/1874285801408010148","volume":"8","author":"H Siddiqui","year":"2014","unstructured":"Siddiqui, H. et al. Pathogens in urine from a female patient with overactive bladder syndrome detected by culture-independent high throughput sequencing: a case report. Open Microbiol. J. 8, 148 (2014).","journal-title":"Open Microbiol. J."},{"key":"1174_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejogrb.2017.04.040","volume":"214","author":"N Curtiss","year":"2017","unstructured":"Curtiss, N. et al. A case controlled study examining the bladder microbiome in women with overactive bladder (OAB) and healthy controls. Eur. J. Obstet. Gynecol. Reprod. Biol. 214, 31\u201335 (2017).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1174_CR33","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1099\/jgv.0.001097","volume":"99","author":"A Garretto","year":"2018","unstructured":"Garretto, A., Thomas-White, K., Wolfe, A. J. & Putonti, C. Detecting viral genomes in the female urinary microbiome. J. Gen. Virol. 99, 1141 (2018).","journal-title":"J. Gen. Virol."},{"key":"1174_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/13550280260422758","volume":"8","author":"H Chang","year":"2002","unstructured":"Chang, H. et al. High incidence of JC viruria in JC-seropositive older individuals. J. Neurovirol. 8, 447\u2013451 (2002).","journal-title":"J. Neurovirol."},{"key":"1174_CR35","doi-asserted-by":"publisher","first-page":"19484","DOI":"10.1038\/s41598-025-98780-9","volume":"15","author":"M Koch","year":"2025","unstructured":"Koch, M. et al. Women suffering from overactive bladder syndrome exhibit a higher urethral viral abundance compared to healthy controls: a pilot study. Sci. Rep. 15, 19484 (2025).","journal-title":"Sci. Rep."},{"key":"1174_CR36","doi-asserted-by":"publisher","first-page":"984234","DOI":"10.3389\/fmicb.2022.984234","volume":"13","author":"Q Sun","year":"2022","unstructured":"Sun, Q. et al. The detection of urinary viruses is associated with aggravated symptoms and altered bacteriome in female with overactive bladder. Front. Microbiol. 13, 984234 (2022).","journal-title":"Front. Microbiol."},{"key":"1174_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1471-2180-12-205","volume":"12","author":"H Siddiqui","year":"2012","unstructured":"Siddiqui, H., Lagesen, K., Nederbragt, A. J., Jeansson, S. L. & Jakobsen, K. S. Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol. 12, 205 (2012).","journal-title":"BMC Microbiol."},{"key":"1174_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/jcm8030415","volume":"8","author":"JC Nickel","year":"2019","unstructured":"Nickel, J. C. et al. A culture-independent analysis of the microbiota of female interstitial cystitis\/bladder pain syndrome participants in the MAPP Research Network. J. Clin. Med. 8, 415 (2019).","journal-title":"J. Clin. Med."},{"key":"1174_CR39","doi-asserted-by":"publisher","first-page":"711746","DOI":"10.3389\/fcimb.2021.711746","volume":"11","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. Combined signature of the urinary microbiome and metabolome in patients with interstitial cystitis. Front. Cell. Infect. Microbiol. 11, 711746 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1174_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04115-5","volume":"21","author":"Z Zheng","year":"2023","unstructured":"Zheng, Z. et al. Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis\/bladder pain syndrome patients. J. Transl. Med. 21, 266 (2023).","journal-title":"J. Transl. Med."},{"key":"1174_CR41","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/JU.0000000000003189","volume":"209","author":"AJ Wolfe","year":"2023","unstructured":"Wolfe, A. J. et al. Detection of bacteria in bladder mucosa of adult females. J. Urol. 209, 937\u2013949 (2023).","journal-title":"J. Urol."},{"key":"1174_CR42","doi-asserted-by":"publisher","first-page":"347.e1","DOI":"10.1016\/j.ajog.2015.07.009","volume":"213","author":"MM Pearce","year":"2015","unstructured":"Pearce, M. M. et al. The female urinary microbiome in urgency urinary incontinence. Am. J. Obstet. Gynecol. 213, 347.e1\u2013347.e11 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1174_CR43","doi-asserted-by":"publisher","first-page":"729.e1","DOI":"10.1016\/j.ajog.2020.04.033","volume":"223","author":"TK Price","year":"2020","unstructured":"Price, T. K. et al. Bladder bacterial diversity differs in continent and incontinent women: a cross-sectional study. Am. J. Obstet. Gynecol. 223, 729.e1\u2013729.e10 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1174_CR44","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3390\/life13051199","volume":"13","author":"A Javan Balegh Marand","year":"2023","unstructured":"Javan Balegh Marand, A. et al. Differences in the urinary microbiome of patients with overactive bladder syndrome with and without detrusor overactivity on urodynamic measurements. Life 13, 1199 (2023).","journal-title":"Life"},{"key":"1174_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fcimb.2016.00078","volume":"6","author":"L Karstens","year":"2016","unstructured":"Karstens, L. et al. Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front. Cell. Infect. Microbiol. 6, 78 (2016).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1174_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12894-022-00990-0","volume":"22","author":"K Li","year":"2022","unstructured":"Li, K. et al. Interplay between bladder microbiota and overactive bladder symptom severity: a cross-sectional study. BMC Urol. 22, 39 (2022).","journal-title":"BMC Urol."},{"key":"1174_CR47","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00192-018-3683-6","volume":"29","author":"YM Komesu","year":"2018","unstructured":"Komesu, Y. M. et al. The urinary microbiome in women with mixed urinary incontinence compared to similarly aged controls. Int. Urogynecol. J. 29, 1785\u20131795 (2018).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR48","doi-asserted-by":"publisher","first-page":"344.e1","DOI":"10.1016\/j.ajog.2023.10.036","volume":"230","author":"MU Carnes","year":"2023","unstructured":"Carnes, M. U. et al. Urinary microbiome community types associated with urinary incontinence severity in women. Am. J. Obstet. Gynecol. 230, 344.e1 (2023).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1174_CR49","doi-asserted-by":"publisher","first-page":"759156","DOI":"10.3389\/fcimb.2022.759156","volume":"12","author":"R Nardos","year":"2022","unstructured":"Nardos, R. et al. Network-based differences in the vaginal and bladder microbial communities between women with and without urgency urinary incontinence. Front. Cell. Infect. Microbiol. 12, 759156 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1174_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-24079-4","volume":"15","author":"J Li","year":"2025","unstructured":"Li, J. et al. Alterations in urinary microbiota composition in children with overactive bladder: insights from 16S rRNA gene sequencing. Sci. Rep. 15, 40455 (2025).","journal-title":"Sci. Rep."},{"key":"1174_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/bju.15519","volume":"129","author":"JC Nickel","year":"2022","unstructured":"Nickel, J. C. et al. The bacterial microbiota of Hunner lesion interstitial cystitis\/bladder pain syndrome. BJU Int. 129, 104\u2013112 (2022).","journal-title":"BJU Int."},{"key":"1174_CR52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00345-019-02764-0","volume":"38","author":"JC Nickel","year":"2019","unstructured":"Nickel, J. C. et al. Urinary fungi associated with urinary symptom severity among women with interstitial cystitis\/bladder pain syndrome (IC\/BPS). World J. Urol. 38, 433 (2019).","journal-title":"World J. Urol."},{"key":"1174_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.juro.2015.09.075","volume":"195","author":"JC Nickel","year":"2015","unstructured":"Nickel, J. C. et al. Assessment of the lower urinary tract microbiota during symptom flare in women with urologic chronic pelvic pain syndrome: a MAPP network study. J. Urol. 195, 356 (2015).","journal-title":"J. Urol."},{"key":"1174_CR54","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2025.01.013","volume":"233","author":"C Cardaillac","year":"2025","unstructured":"Cardaillac, C. et al. Gut, vaginal, and urinary microbiota as potential biomarkers of sensitization in women with chronic pelvic pain. Am. J. Obstet. Gynecol. 233, 103.e1\u2013103.e18 (2025).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1174_CR55","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1152\/physrev.00030.2012","volume":"93","author":"L Birder","year":"2013","unstructured":"Birder, L. & Andersson, K. E. Urothelial signaling. Physiol. Rev. 93, 653\u2013680 (2013).","journal-title":"Physiol. Rev."},{"key":"1174_CR56","doi-asserted-by":"publisher","first-page":"e00439","DOI":"10.1128\/mSphere.00439-19","volume":"4","author":"B Abbasian","year":"2019","unstructured":"Abbasian, B. et al. Potential role of extracellular ATP released by bacteria in bladder infection and contractility. mSphere 4, e00439\u201319 (2019).","journal-title":"mSphere"},{"key":"1174_CR57","doi-asserted-by":"publisher","first-page":"F805","DOI":"10.1152\/ajprenal.00339.2015","volume":"311","author":"A Contreras-Sanz","year":"2016","unstructured":"Contreras-Sanz, A. et al. Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria. Am. J. Physiol. Renal Physiol. 311, F805\u2013F816 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1174_CR58","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1086\/651275","volume":"201","author":"CN Rudick","year":"2010","unstructured":"Rudick, C. N. et al. Host-pathogen interactions mediating pain of urinary tract infection. J. Infect. Dis. 201, 1240\u20131249 (2010).","journal-title":"J. Infect. Dis."},{"key":"1174_CR59","doi-asserted-by":"publisher","first-page":"R396","DOI":"10.1152\/ajpregu.00106.2021","volume":"321","author":"A Rahman-Enyart","year":"2021","unstructured":"Rahman-Enyart, A. et al. Acyloxyacyl hydrolase is a host determinant of gut microbiome-mediated pelvic pain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 321, R396 (2021).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"1174_CR60","doi-asserted-by":"publisher","unstructured":"Gourdine, J.-P. F. et al. Complex carbohydrates catabolism capacity of bladder microbiota inhabiting healthy and overactive female bladders. Preprint at. bioRxiv https:\/\/doi.org\/10.1101\/2025.04.02.646827 (2025).","DOI":"10.1101\/2025.04.02.646827"},{"key":"1174_CR61","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877\u20132013 (2019).","journal-title":"Physiol. Rev."},{"key":"1174_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.urology.2025.05.052","volume":"204","author":"SH Jeong","year":"2025","unstructured":"Jeong, S. H., Vasavada, S. P., Lashner, B. & Werneburg, G. T. Fecal microbiota transplant is associated with resolution of recurrent urinary tract infection. Urology\u00a0204,\u00a069\u201375\u00a0(2025).","journal-title":"Urology"},{"key":"1174_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-025-00705-4","volume":"17","author":"J Hu","year":"2025","unstructured":"Hu, J. et al. Fecal microbiota transplantation alleviates immunosuppressant-associated diarrhea and recurrent urinary tract infection in kidney transplant recipients: a retrospective analysis. Gut Pathog. 17, 28 (2025).","journal-title":"Gut Pathog."},{"key":"1174_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/nau.20817","volume":"29","author":"EE Ustinova","year":"2010","unstructured":"Ustinova, E. E., Fraser, M. O. & Pezzone, M. A. Cross-talk and sensitization of bladder afferent nerves. Neurourol. Urodyn. 29, 77 (2010).","journal-title":"Neurourol. Urodyn."},{"key":"1174_CR65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.autneu.2012.09.002","volume":"173","author":"JJ Fitzgerald","year":"2012","unstructured":"Fitzgerald, J. J., Ustinova, E., Koronowski, K. B., de Groat, W. C. & Pezzone, M. A. Evidence for the role of mast cells in colon\u2013bladder cross organ sensitization. Auton. Neurosci. 173, 6 (2012).","journal-title":"Auton. Neurosci."},{"key":"1174_CR66","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00345-020-03243-7","volume":"39","author":"T Okamoto","year":"2021","unstructured":"Okamoto, T. et al. Altered gut microbiome associated with overactive bladder and daily urinary urgency. World J. Urol. 39, 847\u2013853 (2021).","journal-title":"World J. Urol."},{"key":"1174_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11255-021-03044-w","volume":"54","author":"Y Okuyama","year":"2022","unstructured":"Okuyama, Y. et al. The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan. Int. Urol. Nephrol. 54, 9\u201316 (2022).","journal-title":"Int. Urol. Nephrol."},{"key":"1174_CR68","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.3390\/jcm14124183","volume":"14","author":"H Honda","year":"2025","unstructured":"Honda, H. et al. Association between endogenous equol production and the onset of overactive bladder in postmenopausal women. J. Clin. Med. 14, 4183 (2025).","journal-title":"J. Clin. Med."},{"key":"1174_CR69","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fcimb.2019.00092","volume":"9","author":"KV Meriwether","year":"2019","unstructured":"Meriwether, K. V. et al. The vaginal and urinary microbiomes in premenopausal women with interstitial cystitis\/bladder pain syndrome as compared to unaffected controls: a pilot cross-sectional study. Front. Cell. Infect. Microbiol. 9, 92 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1174_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/srep26083","volume":"6","author":"A Braundmeier-Fleming","year":"2016","unstructured":"Braundmeier-Fleming, A. et al. Stool-based biomarkers of interstitial cystitis\/bladder pain syndrome. Sci. Rep. 6, 26083 (2016).","journal-title":"Sci. Rep."},{"key":"1174_CR71","doi-asserted-by":"publisher","first-page":"e2117904119","DOI":"10.1073\/pnas.2117904119","volume":"119","author":"CH Song","year":"2022","unstructured":"Song, C. H. et al. Lactobacillus crispatus limits bladder uropathogenic E. coli infection by triggering a host type I interferon response. Proc. Natl Acad. Sci. USA 119, e2117904119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1174_CR72","doi-asserted-by":"publisher","first-page":"1547749","DOI":"10.3389\/fphar.2025.1547749","volume":"16","author":"R Bentanachs","year":"2025","unstructured":"Bentanachs, R. et al. Mirabegron induces selective changes in the faecal microbiota of HFHFr rats without altering bile acid composition. Front. Pharmacol. 16, 1547749 (2025).","journal-title":"Front. Pharmacol."},{"key":"1174_CR73","doi-asserted-by":"publisher","first-page":"147","DOI":"10.22141\/2307-1257.14.2.2025.524","volume":"14","author":"HN Hamza","year":"2025","unstructured":"Hamza, H. N., Aziz, H. A. & Azeez, D. A. Physiologic-microbiome interactions in the pathogenesis of genitourinary syndrome of menopause among menopausal stages. Kidneys 14, 147\u2013153 (2025).","journal-title":"Kidneys"},{"key":"1174_CR74","doi-asserted-by":"publisher","first-page":"299200","DOI":"10.3389\/fcimb.2017.00488","volume":"7","author":"P Wu","year":"2017","unstructured":"Wu, P. et al. Urinary microbiome and psychological factors in women with Overactive bladder. Front. Cell. Infect. Microbiol. 7, 299200 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1174_CR75","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1152\/ajprenal.00395.2005","volume":"290","author":"EE Ustinova","year":"2006","unstructured":"Ustinova, E. E., Fraser, M. O. & Pezzone, M. A. Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli: an afferent origin of pelvic organ cross-sensitization. Am. J. Physiol. Ren. Physiol. 290, 1478\u20131487 (2006).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1174_CR76","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1152\/ajpregu.00411.2007","volume":"293","author":"CN Rudick","year":"2007","unstructured":"Rudick, C. N., Chen, M. C., Mongiu, A. K. & Klumpp, D. J. Organ cross talk modulates pelvic pain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, 1191\u20131198 (2007).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"1174_CR77","doi-asserted-by":"publisher","first-page":"e0278918","DOI":"10.1371\/journal.pone.0278918","volume":"17","author":"TC Clarkson","year":"2022","unstructured":"Clarkson, T. C., Iguchi, N., Xie, A. X. & Malykhina, A. P. Differential transcriptomic changes in the central nervous system and urinary bladders of mice infected with a coronavirus. PLoS ONE 17, e0278918 (2022).","journal-title":"PLoS ONE"},{"key":"1174_CR78","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1097\/SPV.0000000000000951","volume":"27","author":"A Soriano","year":"2021","unstructured":"Soriano, A. et al. Relationship of bladder pain with clinical and urinary markers of neuroinflammation in women with urinary urgency without urinary incontinence. Female Pelvic Med. Reconstr. Surg. 27, e418 (2021).","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"key":"1174_CR79","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/nau.25550","volume":"43","author":"N Hashemi","year":"2024","unstructured":"Hashemi, N. et al. A systematic and comprehensive review of the role of microbiota in urinary chronic pelvic pain syndrome. Neurourol. Urodyn. 43, 1859\u20131882 (2024).","journal-title":"Neurourol. Urodyn."},{"key":"1174_CR80","first-page":"552","volume":"13","author":"H Mostafaei","year":"2023","unstructured":"Mostafaei, H. et al. Microbiome in lower urinary tract symptoms (LUTSs): mapping the state of the art with bibliometric. Analysis 13, 552 (2023).","journal-title":"Analysis"},{"key":"1174_CR81","first-page":"259","volume":"18","author":"A Javan Balegh Marand","year":"2021","unstructured":"Javan Balegh Marand, A. et al. Urinary microbiome and its correlation with disorders of the genitourinary system. Urol. J. 18, 259\u2013270 (2021).","journal-title":"Urol. J."},{"key":"1174_CR82","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/nau.23006","volume":"36","author":"MJ Drake","year":"2017","unstructured":"Drake, M. J., Morris, N., Apostolidis, A., Rahnama\u2019i, M. S. & Marchesi, J. R. The urinary microbiome and its contribution to lower urinary tract symptoms; ICI-RS 2015. Neurourol. Urodyn. 36, 850\u2013853 (2017).","journal-title":"Neurourol. Urodyn."},{"key":"1174_CR83","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.euf.2018.09.011","volume":"6","author":"T Antunes-Lopes","year":"2020","unstructured":"Antunes-Lopes, T. et al. The role of urinary microbiota in lower urinary tract dysfunction: a systematic review. Eur. Urol. Focus 6, 361\u2013369 (2020).","journal-title":"Eur. Urol. Focus"},{"key":"1174_CR84","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.3390\/nu15194165","volume":"15","author":"AB Villadsen","year":"2023","unstructured":"Villadsen, A. B. et al. Use of fermented red clover isoflavones in the treatment of overactive bladder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial. Nutrients 15, 4165 (2023).","journal-title":"Nutrients"},{"key":"1174_CR85","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s11255-019-02282-3","volume":"51","author":"BJ Wolff","year":"2019","unstructured":"Wolff, B. J., Price, T. K., Joyce, C. J., Wolfe, A. J. & Mueller, E. R. Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial. Int. Urol. Nephrol. 51, 2149\u20132159 (2019).","journal-title":"Int. Urol. Nephrol."},{"key":"1174_CR86","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s41043-024-00612-5","volume":"43","author":"YZ Du","year":"2024","unstructured":"Du, Y. Z. et al. The relationship between dietary live microbe intake and overactive bladder among American adults: a cross-sectional study from NHANES 2007\u20132018. J. Health Popul. Nutr. 43, 120 (2024).","journal-title":"J. Health Popul. Nutr."},{"key":"1174_CR87","doi-asserted-by":"publisher","first-page":"e0270242","DOI":"10.1371\/journal.pone.0270242","volume":"17","author":"R Yoshikata","year":"2022","unstructured":"Yoshikata, R. et al. Evaluation of the efficacy of Lactobacillus-containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: a pilot randomized controlled trial. PLoS ONE 17, e0270242 (2022).","journal-title":"PLoS ONE"},{"key":"1174_CR88","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41585-024-00974-9","volume":"22","author":"J Pereca","year":"2025","unstructured":"Pereca, J., Wagg, A., Kennedy, M. & Chapple, C. Antibiotic therapy for treating overactive bladder is not supported by clinical evidence. Nat. Rev. Urol. 22, 366\u2013374 (2025).","journal-title":"Nat. Rev. Urol."},{"key":"1174_CR89","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00192-018-3558-x","volume":"29","author":"K Gill","year":"2018","unstructured":"Gill, K., Kang, R., Sathiananthamoorthy, S., Khasriya, R. & Malone-Lee, J. A blinded observational cohort study of the microbiological ecology associated with pyuria and overactive bladder symptoms. Int. Urogynecol. J. 29, 1493\u20131500 (2018).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR90","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00192-023-05703-1","volume":"35","author":"KM Palm","year":"2024","unstructured":"Palm, K. M. et al. The response of the urinary microbiome to botox. Int. Urogynecol. J. 35, 237\u2013251 (2024).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR91","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00192-015-2847-x","volume":"27","author":"KJ Thomas-White","year":"2016","unstructured":"Thomas-White, K. J. et al. Incontinence medication response relates to the female urinary microbiota. Int. Urogynecol. J. 27, 723\u2013733 (2016).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR92","doi-asserted-by":"publisher","first-page":"1030315","DOI":"10.3389\/fcimb.2022.1030315","volume":"12","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z. et al. Unraveling the impact of Lactobacillus spp. and other urinary microorganisms on the efficacy of mirabegron in female patients with overactive bladder. Front. Cell. Infect. Microbiol. 12, 1030315 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1174_CR93","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00192-022-05190-w","volume":"33","author":"T Halverson","year":"2022","unstructured":"Halverson, T., Mueller, E. R., Brubaker, L. & Wolfe, A. J. Symptom improvement with mirabegron treatment is associated with urobiome changes in adult women. Int. Urogynecol. J. 33, 1319\u20131328 (2022).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR94","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00192-022-05416-x","volume":"34","author":"T Halverson","year":"2023","unstructured":"Halverson, T., Mueller, E. R., Brubaker, L. & Wolfe, A. J. Urobiome changes differ based on OAB treatment in adult females. Int. Urogynecol. J. 34, 1271\u20131277 (2023).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR95","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1007\/s00192-023-05664-5","volume":"34","author":"I Gabriel","year":"2023","unstructured":"Gabriel, I. et al. Impact of microbiota and host immunologic response on the efficacy of anticholinergic treatment for urgency urinary incontinence. Int. Urogynecol. J. 34, 3041\u20133050 (2023).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR96","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00192-022-05219-0","volume":"34","author":"MG Mueller","year":"2023","unstructured":"Mueller, M. G. et al. Longitudinal urinary microbiome characteristics in women with urgency urinary incontinence undergoing sacral neuromodulation. Int. Urogynecol. J. 34, 517\u2013525 (2023).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR97","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06546189 (2025)."},{"key":"1174_CR98","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06921746 (2026)."},{"key":"1174_CR99","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06780163 (2026)."},{"key":"1174_CR100","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT07025044 (2026)."},{"key":"1174_CR101","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05557279 (2026)."},{"key":"1174_CR102","doi-asserted-by":"publisher","first-page":"1434117","DOI":"10.3389\/fmicb.2024.1434117","volume":"15","author":"J Gao","year":"2024","unstructured":"Gao, J., Shao, S. & Shen, Y. Causal effects of gut microbiota on risk of interstitial cystitis: a two-sample Mendelian randomization study. Front. Microbiol. 15, 1434117 (2024).","journal-title":"Front. Microbiol."},{"key":"1174_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69543-9","volume":"14","author":"P Jiang","year":"2024","unstructured":"Jiang, P. et al. Mendelian randomization study reveals causal effects of specific gut microbiota on the risk of interstitial cystitis\/bladder pain syndrome (IC\/BPS). Sci. Rep. 14, 18405 (2024).","journal-title":"Sci. Rep."},{"key":"1174_CR104","doi-asserted-by":"publisher","first-page":"1395580","DOI":"10.3389\/fimmu.2024.1395580","volume":"15","author":"C Fu","year":"2024","unstructured":"Fu, C. et al. Gut microbiota and interstitial cystitis: exploring the gut-bladder axis through Mendelian randomization, biological annotation and bulk RNA sequencing. Front. Immunol. 15, 1395580 (2024).","journal-title":"Front. Immunol."},{"key":"1174_CR105","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.maturitas.2016.05.015","volume":"91","author":"AL Muhleisen","year":"2016","unstructured":"Muhleisen, A. L. & Herbst-Kralovetz, M. M. Menopause and the vaginal microbiome. Maturitas 91, 42\u201350 (2016).","journal-title":"Maturitas"},{"key":"1174_CR106","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/ijgo.70125","volume":"170","author":"S Gupte","year":"2025","unstructured":"Gupte, S. et al. The role of gut and vaginal microbiomes in reproductive health: Implications for PCOS, endometriosis, pre-eclampsia, and beyond. Int. J. Gynaecol. Obstet. 170, 1084\u20131090 (2025).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"1174_CR107","doi-asserted-by":"publisher","first-page":"727.e1","DOI":"10.1016\/j.ajog.2020.08.006","volume":"223","author":"K Thomas-White","year":"2020","unstructured":"Thomas-White, K. et al. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms. Am. J. Obstet. Gynecol. 223, 727.e1\u2013727.e11 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1174_CR108","doi-asserted-by":"publisher","unstructured":"Janes, V. A. et al. Metagenomic sequencing to replace semi-quantitative urine culture for detection of urinary tract infections: a proof of concept. Preprint at. bioRxiv https:\/\/doi.org\/10.1101\/178178 (2017).","DOI":"10.1101\/178178"},{"key":"1174_CR109","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1126\/science.adk4271","volume":"383","author":"DE Hoffmann","year":"2024","unstructured":"Hoffmann, D. E. et al. The DTC microbiome testing industry needs more regulation. Science 383, 1176\u20131179 (2024).","journal-title":"Science"},{"key":"1174_CR110","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s42003-025-09301-3","volume":"9","author":"SL Servetas","year":"2026","unstructured":"Servetas, S. L., Gierz, K. S., Hoffmann, D., Ravel, J. & Jackson, S. A. Evaluating the analytical performance of direct-to-consumer gut microbiome testing services. Commun. Biol. 9, 269 (2026).","journal-title":"Commun. Biol."},{"key":"1174_CR111","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2468-1253(24)00311-X","volume":"10","author":"S Porcari","year":"2025","unstructured":"Porcari, S. et al. International consensus statement on microbiome testing in clinical practice. Lancet Gastroenterol. Hepatol. 10, 154\u2013167 (2025).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1174_CR112","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","volume":"21","author":"L Leitner","year":"2021","unstructured":"Leitner, L. et al. Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. Lancet Infect. Dis. 21, 427\u2013436 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1174_CR113","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1473-3099(24)00424-9","volume":"24","author":"P Kim","year":"2024","unstructured":"Kim, P. et al. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Lancet Infect. Dis. 24, 1319\u20131332 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1174_CR114","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41591-019-0600-6","volume":"25","author":"A Lev-Sagie","year":"2019","unstructured":"Lev-Sagie, A. et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat. Med. 25, 1500\u20131504 (2019).","journal-title":"Nat. Med."},{"key":"1174_CR115","doi-asserted-by":"publisher","first-page":"101294","DOI":"10.1016\/j.lanmic.2025.101294","volume":"7","author":"T Wr\u00f8nding","year":"2026","unstructured":"Wr\u00f8nding, T. et al. Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis. Lancet Microbe 7, 101294 (2026).","journal-title":"Lancet Microbe"},{"key":"1174_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-11-244","volume":"11","author":"H Siddiqui","year":"2011","unstructured":"Siddiqui, H., Nederbragt, A. J., Lagesen, K., Jeansson, S. L. & Jakobsen, K. S. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol. 11, 244 (2011).","journal-title":"BMC Microbiol."},{"key":"1174_CR117","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s00192-019-03942-9","volume":"30","author":"L Bresler","year":"2019","unstructured":"Bresler, L. et al. Female lower urinary tract microbiota do not associate with IC\/PBS symptoms: a case-controlled study. Int. Urogynecol. J. 30, 1835\u20131842 (2019).","journal-title":"Int. Urogynecol. J."},{"key":"1174_CR118","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00192-021-04812-z","volume":"33","author":"A Shatkin-Margolis","year":"2022","unstructured":"Shatkin-Margolis, A. et al. The effect of mindfulness-based stress reduction on the urinary microbiome in interstitial cystitis. Int. Urogynecol. J. 33, 665\u2013671 (2022).","journal-title":"Int. Urogynecol. J."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01174-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:22:51Z","timestamp":1785518571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01174-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":118,"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1038\/s41585-026-01174-3","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"29 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}